Commercially reared food animals encounter serial pathogenic and nonpathogenic immune challenges throughout production. Because of the diversion of nutrients away from growth in support of immune-related processes, immune challenge is considered a major obstacle to animals' achieving their genetic potential for growth or efficiency of gain. Scientists now recognize that many metabolic processes respond directly or indirectly to proinflammatory cytokines. This cytokine-mediated "reprogramming" of metabolism is a homeorhetic mechanism that ensures an adequate supply of nutrients for proliferation of lymphocyte and macrophage populations, antibody production, and hepatic synthesis of acute phase proteins. Proinflammatory cytokines have been linked to altered nutrient uptake and utilization. Anabolic processes are interrupted, and companion catabolic activities are amplified. Furthermore, cytokines may influence prenatal growth and development, and to the extent that postnatal proliferation and differentiation of myogenic and adipogenic cells contribute to postnatal growth, cytokine regulation of these events may ultimately influence growth. The following discussion is an overview of the impact of immune challenge and proinflammatory cytokines on metabolism and growth.
Introduction
The detrimental effect of disease and immunological stress on growth rate and efficiency of gain in food animals is of considerable economic importance. The potential for improved profitability and animal wellbeing has led scientists to investigate the mechanisms by which clinical and subclinical disease challenges influence growth and efficiency of gain. Early work by Klasing et al. (1987) and Klasing (1988) established the tenet that cytokines not only regulate immune function but also modify the growth process. It is now readily apparent that the regulatory jurisdiction of cytokines, particularly interleukin-1 3 ( IL-1) , interleukin-6 ( IL-6) , and tumor necrosis factor 4 ( TNF) , extends well beyond the immune system. Receptors for several proinflammatory cytokines are common to many cell types and allow direct regulation of nutrient metabolism and growth. Furthermore, cytokines may invoke other immune modulators such as glucocorticoids, prostaglandins, and catecholamines, all of which may affect cell metabolism and growth. Because a myriad of physiological events impacted in some way by cytokines has been identified, a prevailing hypothesis has evolved. This hypothesis states that during periods of immune challenge, proinflammatory cytokines orchestrate a homeorhetic response in which nutrients are directed away from tissue growth in support of immune function. Furthermore, the consensus among scientists is that even when disease is subclinical in nature, the cumulative effect of the serial challenges is sufficient to cause significant alterations in metabolism with concurrent losses in performance. The following discussion is an overview of how immunological stress may suppress growth in food animals and will be directed at specific metabolic systems regulated directly or indirectly by proinflammatory cytokines. 5 Segregated early weaning of pigs is a production scheme designed to limit antigen exposure and improve growth performance after weaning.
Growth Hormone, Insulin-Like Growth Factor-I, and the Insulin-Like Growth Factor Binding Proteins
Growth Hormone. Growth hormone is a key anabolic hormone and it is only logical that the somatotropic axis has been evaluated in rodents and some food animal as a potential mediator of the attenuated growth during immune challenge. The relationship between suppressed growth and growth hormone (GH) is likely multifaceted. A diminution in pulsatile release and baseline blood concentrations may lead to reductions in direct and indirect (i.e., insulin-like growth factor I [IGF-I-mediated) anabolic activity. Additionally, although not yet substantiated in the literature, tissue-specific changes in receptor function and postreceptor signaling may occur. The present discussion addresses GH release from the pituitary and changes in circulating concentrations. The IGF-I relationship is addressed separately. In rats, GH concentrations are reduced during endotoxin challenge (Fan et al., 1994 (Fan et al., , 1995a ) and pulsatile release is transiently suppressed (Peisen et al., 1995) . The latter study (Peisen et al., 1995) establishes a strong link between IL-1, IL-1b specifically, and the suppressed GH release for several reasons. First, intraventricular (third ventricle) delivery of IL-1 receptor antagonist neutralizes the effect of endotoxin on GH concentrations.
Second, release of GH-releasing hormone ( GHRH) from medial basal hypothalamic explants is decreased by IL-1b, whereas somatostatin release is increased. Finally, the GHRH and somatostatin responses are abrogated by simultaneous incubation with the interleukin receptor antagonist. Interleukin-1b may be further implicated in that lipopolysaccharide ( LPS) injection causes a reduction in the plasma GH concentration that cannot be normalized by neutralization of TNFa with anti-TNF antibody (Fan et al., 1995a) . Such a response can be rationalized considering the typical induction of IL-1a and IL-1b by endotoxin.
In food animals, the GH response to immune challenge is variable. Reduced blood concentrations have been documented in challenged cattle (Elsasser et al., 1987; Elsasser, 1988; Kenison et al., 1991) . In contrast, studies indicate that GH concentrations in challenged sheep increase; concentrations increase coincident with increased GH release from the pituitary gland of sheep challenged with endotoxin (Coleman et al., 1993) , and cultured sheep pituitary cells respond to incubation with endotoxin by increasing GH release into the culture medium (Coleman and Sartin, 1996) . In pigs, the overall impact of immune challenge on the somatotropic axis seems minimal. Although endotoxin challenge reduces the frequency of pulsatile release, there is an acute increase in blood GH with little or no impact on basal concentrations longer-term ( 6 h, Hevener et al., 1996) . We have obtained similar results (unpublished data): 1 and 4 h following endotoxin injection, blood GH concentrations were similar in challenged and control pigs.
Insulin-Like Growth Factor-I. The anabolic action of GH is accomplished in part by the induction of IGF-I in liver and perhaps skeletal muscle. There are clear indications across numerous animal models that reduced blood concentrations of IGF-I, frequently independent of feed intake, accompany an immune challenge. Calves (Elsasser et al., 1987; Elsasser, 1988) and pigs (Prickett et al., 1992) infected with Sarcocystis cruzi and Sarcocystis meischeriana, respectively, have lower plasma IGF-I concentrations and reduced growth rates. Conventionally weaned pigs have lower serum IGF-I concentrations than pigs weaned according to segregated early-weaned 5 (SEW) procedures (Hathaway et al., 1993) and typically have poorer growth performance. Furthermore, higher serum concentrations of IGF-I in growing pigs fed antimicrobial agents have been associated with improved growth performance relative to control pigs (Hathaway et al., 1996) .
Reductions in blood IGF-I concomitant with immune challenge likely reflect decreased synthesis in multiple tissues. In rats, endotoxin challenge (Fan et al., 1994) or IL-1b causes acute declines in plasma, liver, skeletal muscle, and pituitary IGF-I, and liver and skeletal muscle IGF-I mRNA abundance is reduced in rats receiving IL-1b vs controls. It is also interesting that the normal regulatory linkage between GH and IGF-I may be uncoupled during immunological stress. In the study by Fan et al. (1994) , a reduction (> 80%) in plasma GH preceded the drop in IGF-I, and whereas plasma GH returned to normal between 8 and 24 h, IGF-I was still decreased at 24 h. Furthermore, IGF-I concentrations in septic patients cannot be normalized by exogenous GH (Dahn et al., 1988) , and we have been unable to prevent the acute drop in serum IGF-I in pigs injected with lipopolysaccharide by pre-and postchallenge administration of recombinant porcine GH (unpublished data).
Reducing circulating concentrations of IGF-I seems to be an integral component of the homeorhesis necessary to support the immune response. A strong link between IGF-I status and the homeorhesis of immune challenge is evident in that 1 ) administration of recombinant IGF-I to lambs infused with TNF reduces the rate of net protein loss and improves peripheral glucose clearance (Douglas et al., 1991) , and 2 ) protein synthesis in vivo (gastrocnemius .
Insulin-Like Growth Factor Binding Proteins. The
IGF binding proteins ( IGFBP) regulate IGF-I activity and consequently influence growth (see Kelley et al., 1996 for a detailed review). Changes in specific IGFBP in blood and other tissues have been associated with immune challenge (summarized in Table 1 ). Binding proteins respond to parasite infection (Elsasser et al., 1987; Prickett et al., 1992) , endotoxin challenge (Fan et al., 1994) , and specific cytokines (Fan et al., 1995a (Fan et al., ,b, 1996 . To date, IGFBP1 has the strongest link to catabolic states and is increased in multiple tissues during immune challenge (Table 1) . Such increases are likely in response to lower insulin and(or) increased glucocorticoid concentrations, both of which are common immune responses in several species. In contrast, IGFBP3 largely facilitates the action of IGF-I and responds positively to GH, perhaps in part via IGF-I. During an immune challenge when plasma GH and IGF-I concentrations were lower, liver IGFBP3 increased whereas concentrations in skeletal muscle and other tissues remained unchanged (Fan et al., 1994) . The biological explanation for this tissuespecific increase is not clear but there are at least two possibilities. First, it seems possible that the liver acts as a sink for this binding protein during periods of reduced anabolic potential, perhaps facilitating the clearance of IGF-1 from the circulation. Second, it is possible that the increased IGFBP3 maintains a higher localized concentration of IGF-I and thus facilitates the metabolic activity of the liver (i.e., acute phase protein [ACP] synthesis) in the face of reduced blood IGF-I concentrations. However, the role of IGF-I in liver metabolism is uncertain. In summary, proinflammatory cytokines released during periods of immune challenge may be potent direct or indirect regulators of GH, IGF-I, and the IGFBP. Altered systemic and localized concentrations of these proteins may permit increases in catabolic components of the immune response, as has been suggested in the case of rheumatoid arthritis (Rall et al., 1996) , and(or) lower anabolic activity. Although the data pertaining to GH in food animals indicate that lower blood concentrations may not be as important as in rodents, IGF-I and the IGFBP are clearly implicated. The IGFBP clearly represent another tier of IGF-I regulation via their influence on availability and bioactivity of IGF-I and may have biological activities independent of IGF-I. One or more of the IGFBP will likely prove to be a significant component of the homeorhesis and perhaps the depressed growth caused by immune challenge.
Insulin Activity and Nutrient Transport and Utilization
Glucose. In immune-challenged animals, glucose uptake by peripheral tissues is dampened as a means of repartitioning energy to meet the needs of specific cell populations and tissues responsible for mounting the immune response. Thus, cytokine-induced alterations in insulin function are not surprising. Sophisticated whole-animal studies involving euglycemic hyperinsulinemic clamps in combination with primed constant tracer infusion established quite clearly that LPS or IL-1 (Ling et al., 1994) and TNF (Lang et al., 1992; Ling et al., 1994) reduced the apparent rate of glucose uptake by skeletal muscle, heart, and liver. Peripheral tissue insulin resistance was evident in that 1 ) endotoxin or cytokine administration reduced the rate of glucose infusion necessary to maintain 6 Glut1 is the insulin-independent glucose transport protein.
7 Glut4 is the insulin-responsive glucose transport protein. 8 C/EBP-a is a transcription factor thought to regulate Glut4 gene expression. euglycemia during hyperinsulinemic conditions and 2 ) cytokines blocked the typical suppression of hepatic gluconeogenesis by insulin.
The mechanisms by which cytokines influence insulin receptor signaling and glucose uptake are not known. However, it is evident that the insulin resistance in skeletal muscle and adipose tissue is multifaceted, encompassing the availability of insulin receptors and glucose transporters and abnormalities in the downstream signal transduction cascade (Moller and Flier, 1992) . In vitro studies with myotube cultures indicate that basal ( Glut1 6 ) and insulin-stimulated ( Glut4 7 ) glucose transport is reduced by TNF. The Glut4 gene expression is depressed in L6 myotubes when exposed to the monokine milieu secreted by endotoxin-stimulated macrophages (Cornelius et al., 1989) . More recently, Zeller et al. (1994) failed to detect a change in the Glut4 content of skeletal muscle membrane prepared from rats challenged with endotoxin, but it is possible that the timing of sample collection precluded detectable changes.
Regarding insulin signaling, the preponderance of available data has been obtained with rodent models and pertains to TNF. Several rodent models of obesity express high levels of TNF in the adipose tissue (Hotamisligil et al., 1993) . Furthermore, these researchers have determined that neutralizing circulating TNF in fa/fa obese rats with a soluble TNF receptor-immunoglobulin G ( IgG) chimeric fusion protein necessitates a greater glucose infusion rate to maintain euglycemia during hyperinsulinemic-euglycemic clamp periods. Improved peripheral glucose uptake, rather than suppressed hepatic glucose production, accounted for the increased insulin sensitivity.
Tumor necrosis factor seems to exert a direct effect on insulin function. Pekala (1991, 1992) and Hotamisligil et al. (1994b) have shown that chronic exposure of 3T3-L1 adipocytes to TNF results in these cells becoming refractory to insulin stimulation and thus a marked depression in insulinmediated glucose transport. Tumor necrosis factor down-regulates the expression of Glut4 and the CCAAT/enhancer binding protein (C/EBP-a 8 , Pekala, 1991, 1992) and reduces cellular membrane Glut4 content. Tumor necrosis factor dampens phosphorylation of the insulin receptor substrate 1 ( IRS-1; Saad et al., 1992; Hotamisligil et al., 1994b) and also autophosphorylation of the insulin receptor ( IR) itself (Hotamisligil et al., 1994a) . These defective phosphorylation cascades in muscle and fat tissues of the Zucker rat (an animal that chronically overexpresses TNF) can be normalized by neutralization of TNF with a TNF receptorIgG fusion protein (Hotamisligil et al., 1994a) . It is also noteworthy that defective phosphorylation cascades can also be induced by other cytokines (TNFb, IL-1, IL-6, IL-11, and interferon) common to infection (Hotamisligil et al., 1994b) .
The apparent role of TNF in altered insulin function is not limited to impaired autophosphorylation of the IR and phosphorylation of IRS-1. reported that this cytokine also blocks insulin-stimulated phosphorylation (activation) of mitogen-activated protein kinase ( MAPK) and its upstream activator, MAPK kinase, in cultured L6 muscle cells. These authors suggested inactivation of the MAPK signaling pathway may be the second loci of insulin resistance associated with TNF. Given that all known biological functions of insulin are predicated upon kinase activities, defective phosphorylation cascades are likely critical components of the insulin resistance and impaired growth associated with disease states in which TNF and other cytokines are elevated.
Amino Acids. A principal objective of the homeorhetic and catabolic activities that accompany immune challenge is ensuring that liver supplies of amino acids are sufficient to meet the increased requirements for glucogenic amino acids and synthesis of ACP. Indeed, the liver becomes the principal organ for amino acid uptake during infection (Austgen et al., 1991) as the capacities of hepatic amino acid transport systems are increased. Inflammatory agents such as invading bacteria and their toxins stimulate the secretion of cytokines and stress hormones that augment hepatic blood flow, amino acid transporter numbers, and transport kinetics (Fischer et al., 1995) . Endotoxemia (Inoue et al., 1994) and TNF treatment (Pacitti et al., 1993) have been associated with increased amino acid transport (increased V max , systems A, N, and ASC) by hepatocyte plasma membrane vesicles, an effect clearly abrogated by pretreatment with anti-TNF antibody (Inoue et al., 1994) . Furthermore, the cytokines, particularly TNF, have been concretely linked to the stimulation of hepatic amino acid transport in cancer models (see Inoue et al., 1995 . Fischer et al., 1996a , another physiological state in which amino acids are repartitioned to the liver at the expense of peripheral tissues.
As noted above, enhanced liver uptake is driven by a concerted action of cytokines and glucocorticoids and recent studies have clarified the nature of this hormonal interaction. Dexamethasone and IL-6 act synergistically to facilitate hepatic amino acid uptake; the V max of the neutral and acidic transport channels is increased (Watkins et al., 1994) . Additional work by this laboratory (Fischer et al., 1996b) showing that glucocorticoids induce IL-6 receptor expression has led to speculation that up-regulation of the IL-6 receptor primes hepatocytes for stimulation by IL-6. In contrast to liver, some skeletal muscle amino acid uptake mechanisms may be suppressed during periods of immunological stress by the same hormonal milieu that enhances uptake in the liver. aAminoisobutyric acid 9 ( AIB) uptake by soleus muscle of rats injected with either TNF or Il-1 is decreased (Zamir et al., 1993a) . The effect of TNF is alleviated by the glucocorticoid receptor antagonist RU38486, whereas that of IL-1 is not. Although TNF has also been implicated in the decreased basal amino acid uptake by system A (reduced V max and K m ) in a rat model of cachexia (García-Martínez et al., 1995b) , it is not yet clear whether these effects are direct or mediated by IL-1 that is induced by TNF. Glucocorticoid antagonist may simply suppress the induction of IL-1 release by TNF.
Insulin resistance may have less impact on amino acid transport than on glucose uptake. In fact, a reduction in insulin-stimulated amino acid transport may not be a direct target of the proinflammatory cytokines. García-Martínez et al. (1993b) concluded that insulin-stimulated AIB (system A ) uptake by soleus and extensor digitorum longus preparations from rats injected with TNF was actually increased relative to the control group. Other work from this group (García-Martínez et al., 1995b) has shown insulin-stimulated amino acid uptake in skeletal muscle preparations to be similar in control rats and those bearing the Yoshida AH-130 ascites hepatoma in which blood concentrations of TNF are chronically increased. Thus, net reductions in skeletal muscle amino acid concentrations may reflect accelerated efflux (discussed separately) and reduced basal transport activity rather than insulin resistance.
In summary, the scenario that has evolved is one in which peripheral tissues such as skeletal muscle and adipose tissue are deprived of nutrients by modifications in insulin responsiveness and nutrient transport mechanisms orchestrated by TNF and other proinflammatory cytokines. It will indeed be interesting to determine in food animals whether management strategies designed to limit disease transmission influence markers of insulin action or nutrient transport systems.
Amino Acid Flux and Oxidation. In keeping with newly established metabolic priorities, infection and inflammatory processes are generally accompanied by an increase in the flux of some amino acids from skeletal muscle pools to the liver. Furthermore, oxidation of branched-chain amino acids ( BCAA) by skeletal muscle may increase as glucose is conserved for other metabolic needs. Cytokine-induced changes in both tissue and plasma amino acid concentrations reflect this altered metabolic state. Skeletal muscle is depleted of several essential and nonessential amino acids after a single injection of TNF (Tayek, 1996) , and with the exception of phenylalanine, alanine, and tryptophan, plasma amino acid concentrations generally decrease during an immune challenge (Wannemacher, 1977). As summarized in Table 2 , we have determined in the pig that within 4 h, a single injection of endotoxin results in > 55% increase in plasma alanine relative to initial baseline concentrations and almost threefold higher concentrations relative to pair-fed controls. In contrast to the observations of Wannemacher (1977) , significant increases rather than reductions (at least at 4 h after injection) were noted for numerous amino acids. Also, the dramatically different response to simple intake restriction (pair-fed control) vs immune challenge is evident in that the changes in plasma amino acids such as alanine and glycine in these two groups were markedly different.
Recently, García-Martínez et al. (1995a) evaluated BCAA metabolism in rats challenged by cecal ligation and puncture, and injection of endotoxin, TNF, or IL-1. Whole-body leucine oxidation was determined based on quantification of 14 CO 2 following a bolus injection of [ 14 C]leucine. All of the challenge protocols resulted in increased leucine oxidation, independent of changes in glucocorticoids. However, when TNF and IL-1 were evaluated in vitro using isolated soleus muscle preparations, neither cytokine influenced leucine oxidation. It is possible that the effect of these cytokines is indirect and(or) that soleus muscle is poorly equipped with the enzymes necessary for transamination and oxidative decarboxylation of BCAA. The necessity of evaluating cytokine function in muscles of differing fiber type composition seems important to gaining a clear understanding of how amino acid metabolism is modified in challenged animals.
Protein Metabolism
Protein Degradation and Synthesis. Because skeletal muscle protein accretion in the growing animal is a reflection of the balance between protein synthesis and degradation rates, disease and stress-related perturbations of both processes are of much interest to food animal scientists. In challenged animals, three factors likely contribute to lower protein synthesis and accelerated protein degradation rates. First, challenge is generally associated with lower feed intake (reviewed by Johnson, 1997) . Thus, the supply of amino acids for protein synthesis is limited. Second, the nitrogen needs of the challenged animal for synthesis of ACP and other immune-related processes may impose a surprising burden on the animal. It has been calculated for humans that nitrogen needs for synthesis of ACP alone may peak at 1.2 g·kg of BW −1 ·day −1 (Waterlow, 1991) . Finally, the amino acid composition of skeletal muscle may be different from that of ACP, thus necessitating that total amino acid release from skeletal muscle exceed that required for ACP synthesis (Reeds et al., 1994) . Thus, it is not surprising that protein losses during an immunological challenge are greater than those caused by reduced feed intake (Tracey et al., 1988) .
Both TNF and IL-1 have been linked to depressed protein synthesis and(or) increased degradation rates in rodent models of immune challenge. Administration of TNF typically leads to an increase in skeletal muscle protein degradation rates (Zamir et al., 1992; Llovera et al., 1993a,b) with no change (Zamir et al., 1992) or an increase (Llovera et al., 1993a,b) in synthesis rates. However, even when synthesis rates are increased, the magnitude of the change in degradation exceeds that of synthesis such that a net loss in protein results.
Whether the effect of TNF on protein accretion is direct or mediated by associated hormonal changes (e.g., glucocorticoids) is not well established. Antibody neutralization of TNF has been shown to negate its effect on protein degradation (Zamir et al., 1992; Costelli et al., 1993) , but in rats injected with Yoshida AH-130 ascites hepatoma cells ( a model of cancer cachexia), polyclonal antiserum to TNF normalized protein degradation rates and abrogated changes in corticosterone status (Costelli et al., 1993) . Other investigations (Hall-Angeras et al., 1990; Mealy et al., 1990 ) also indicate that TNF-induced proteolysis is dependent on glucocorticoids. Results from our laboratory (unpublished data) are consistent with these observations; neither TNF, IL-1, nor the combination of both cytokines increased protein degradation in L8 myotube cultures. A direct effect of these cytokines was evident only in that myosin and total cellular protein synthesis was increased.
Whereas TNF has been the primary focus of many laboratories because of its association with cachexia, the effects of other cytokines on protein degradation are evident in vivo and in vitro. Injections of IL-1 increase total (45%) and myofibrillar (167%) protein degradation in incubated extensor digitorum longus muscle in control and adrenalectomized rats (Zamir et al., 1993b) . Furthermore, although IL-6 has not been routinely considered an initiator of protein degradation, Ebisui et al. (1995) determined that this cytokine accelerates the degradation rates of some proteins in C2C12 myotube cultures. Others (Tsujinaka et al., 1996) have shown that an anti-IL-6 receptor antibody blocks increased expression of protease genes and muscle atrophy in IL-6 transgenic mice.
Finally, it should also be noted that cytokinemediated release of nutrients from tissue stores may include tissues other than skeletal muscle. Evans et al. (1993) identified the intestinal tract as a possible donor of amino acids for synthetic processes and carbon for glucogenesis. These authors found that infusing dogs with TNF increased urinary nitrogen excretion without a corresponding increase in the flux of amino acids from hindlimb muscle. Furthermore, enterectomy blocked the increased urinary nitrogen disposal. We have found that intestinal expression of the stress-responsive 70-kDa stress protein ( HSP72) is increased in pigs injected with endotoxin (McComb and Spurlock, 1997) . These physiological responses in the intestine are perhaps linked and related to the catabolic state induced by endotoxin; at least one member of the 70-kDa stress protein family has been shown to facilitate the passage of proteins bearing specific peptide motifs into lysosomal compartments for proteolysis (Terlecky et al., 1991) .
Activation of multiple proteolytic systems likely ensures adequate amino acid supplies for priority metabolic processes. Identification and characterization of the proteolytic systems that respond directly or indirectly to cytokines will undoubtedly facilitate our understanding of the changes in protein accretion associated with immune challenges.
Cathepsins B and L and proteasome seem to respond to IL-6 (Ebisui et al., 1995) , and calpastatin (the inhibitory regulator of the nonlysosomal calciumdependent proteases, m-and m-calpain) activity tends to be reduced in pigs challenged with endotoxin vs pair-fed controls (Chavis et al., 1994) . Also, increased expression of cathepsin D, m-calpain, ubiquitin, and ubiquitin-conjugating enzyme in the muscle of head trauma patients during states of negative nitrogen balance has been associated with increased concentrations of IL-1b and IL-6 (Mansoor et al., 1996) .
The ubiquitin system of nonlysosomal protein degradation has been linked strongly to diseaserelated increases in protein degradation. García-Martínez et al. (1993a) evaluated ubiquitinization of rat skeletal muscle following injection of TNF and reported a time-dependent increase in conjugated ubiquitin. The effect was more pronounced in soleus than in extensor digitorum longus muscle, which the authors attributed to faster protein turnover rates characteristic of red vs white myofibers. These researchers have since demonstrated that skeletal muscle ubiquitin expression is increased by TNF administration (García-Martínez et al., 1994) , and others (Llovera et al., 1996) have shown that antibody neutralization of TNF normalizes ubiquitin expression in a rat model of cachexia in which the cytokine is characteristically increased.
Lipid Metabolism
Lipolysis and Lipogenesis. The catabolic response mediated by cytokines in challenged humans and animals encompasses major shifts in lipid metabolism. Energy intake is typically reduced during periods of immune challenge and fatty acid oxidation is increased to provide energy. Tumor necrosis factor seems to be a significant mediator of the lipolytic response. Green et al. (1994) applied conditioned medium (i.e., medium collected after macrophages are stimulated immunologically by LPS) to primary rat adipocyte cultures and found glycerol release (an indicator of lipolysis) to almost double. The response was reversed by the removal of conditioned medium, could not be reproduced by medium conditioned by nonstimulated macrophages, and was abolished when the medium was neutralized with a polyclonal antiserum to mouse TNF. Lipolytic responses have also been achieved, at least in the 3T3-F442A adipogenic cell line, with IL-1, interferon-a, and interferon-g Doerrler et al., 1994) , and interferonb .
The mechanism(s) by which tumor necrosis factor (and perhaps other cytokines) augment lipolysis in 3T3-F442A cells was initially attributed to the induction of prostaglandin synthesis . However, varied results have been obtained and recent data (Hardardóttir et al., 1992) indicate other factors because 1 ) low concentrations of prostaglandin synthesis inhibitors prevent prostaglandin release without altering the lipolytic activity of TNF and 2 ) other cytokines induced lipolysis with only negligible prostaglandin production. The cyclic AMP-dependent protein kinase pathway has also been evaluated (Doerrler et al., 1994) , but there seems to be no link between this kinase system and cytokinemediated lipolysis. A study by Green et al. (1994) provided convincing evidence that TNF-induced lipolysis in primary rat adipocyte cultures is also unrelated to an increase in the amount of immunoreactive hormone sensitive lipase ( HSL) . These authors proposed an intriguing hypothesis regarding cytokineinduced expression of a novel kinase for which HSL is a substrate. Identification of this novel kinase and determination of its tissue distribution and regulatory elements may lead to significant advancements in our understanding of cytokine regulation of growth processes.
Regarding lipogenesis in adipocytes, regulation by cytokines presents a rather complex mechanistic picture in that coordinate regulation of the expression of key lipogenic genes and their enzymatic activity is not always apparent. A summary of a thorough evaluation (Doerrler et al., 1994) of lipogenic regulation by proinflammatory cytokines in 3T3-F442A cells is reproduced in Table 3 . Fatty acid synthesis was stimulated by IL-1 but reduced by TNF, IFN-a, and IFN-t. Moreover, it is clear from these data that proinflammatory cytokines target different steps in the lipogenic pathway and that changes in mRNA abundance do not necessarily parallel observed metabolic changes.
Lipoprotein lipase ( LPL) also seems to be a target of cytokines and may play an active part in the homeorhetic response in diseased animals. This enzyme hydrolyzes circulating lipoprotein triglycerides to free fatty acids and monoacylglycerol for cellular uptake. Depressed LPL activity and expression may thus contribute to the hypertriglyceridemia common to infection in humans and rodent species. It has been suggested that the hypertriglyceridemic response is a specific response in which the lipoproteins bind circulating antigens, rendering them less immunogenic Grunfeld and Feingold, 1992) . Thus, it is not surprising that the inflammatory response would include suppressed LPL activity as one means of accumulating lipid in the blood. Multiple cytokines have been shown to regulate LPL activity and expression (Doerrler et al., 1994) , and Ogawa et al. (1989) have shown that TNF and IL-1 act synergistically to suppress LPL activity in 3T3-L1 adipocytes. Transcriptional regulation by TNF of LPL expression has now been traced to this cytokine's regulation of two distinct LPL promoter binding proteins (Morin et al., 1995) . Although the effects of cytokines on LPL expression and activity are well established, our laboratory (unpublished data) and others (Webel et al., 1997) have been unable to document hypertriglyceridemia as a response to LPS in pigs despite marked increases in circulating cytokines.
Alterations of Fetal Growth and Development by Immune Challenge of Pregnant Females
The possible avenues by which immune challenge may influence growth and development has expanded to include the potential for challenge of pregnant females to influence fetal growth and development. The localization of some cytokines to specific cell types in the developing fetus and the discovery that fetal mononuclear cells are as capable as maternal cells of expressing IL-8 in response to a disease challenge (Taniguchi et al., 1993) have posed the possibility that fetal growth and development may be altered if challenges are incurred during gestation. Stallmach et al. (1995) documented the presence of numerous cytokines, including IL-1, TNF, IL-6, and IL-8, in human amniotic fluid, and the latter three also in fetal blood. In particular, increased concentrations of IL-6 and IL-8 in fetal blood were associated with intrauterine growth retardation and(or) chorioamnionitis. Thus, it is conceivable that in utero exposure of the developing fetus to some proinflammatory cytokines compromises development in food animal species.
Placental Amino Acid Transport. Placental amino acid transport may be compromised by cytokines or other immune modulators. Acute administration of TNF to pregnant rats results in marked changes in placental transfer of nonmetabolizable amino acid analogs (Carbo et al., 1995) , as indicated by reduced accumulaton of the analogs in whole fetus and liver. Thus, during the acute phase of an immune challenge, reduced nutrient availability may lead to impaired growth and development of the fetus, particularly if the challenge occurs during a critical stage of development. Nonetheless, a subsequent study by this group (Carbo et al., 1996) using a tumor (Yoshida AH-130 ascites hepatoma) model in which blood TNF concentrations are chronically increased showed that fetal growth was not compromised by the challenge. The sustained growth was attributed to enhanced placental amino acid transport as indicated by alanine (increased V max ) and leucine (reduced K m and increased V max ) transport kinetics. Chronic administration of TNF in this study gave similar results.
Proliferation and Differentiation. Proliferation and differentiation of myogenic and adipogenic cells is a crucial aspect of development. Both of these cell populations may be affected by proinflammatory cytokines. Differentiation of porcine preadipocytes is suppressed in vitro by adding either TNF or serum collected from infected pigs to the culture medium (Jewell et al., 1988), and McNamara et al. (unpublished data) determined that proliferation is reduced by TNF. Others (Torti et al., 1985) found a dedifferentiation phenomenon in mature adipocytes exposed to TNF. These de-differentiated cells required stimulation with the appropriate hormonal milieu for re-differentiation.
Similar proliferation and differentiation responses have been documented in myoblasts. Using L8 myogenic cells, we have determined that proliferation and differentiation (i.e., formation of multinucleated myotubes) are markedly reduced by IL-1 and TNF (unpublished data). Furthermore, TNF and IFN-t (Bartoccioni et al., 1994) and TNF and IL-1 (unpublished data) act synergistically at low physiological concentrations to suppress myoblast proliferation. Such synergisms among cytokines are not surprising considering the overlap in signal transduction pathways. However, opposing responses are also evident. Myoblasts proliferate in response to IL-6 (Austin and Burgess, 1991; Cantini et al., 1995) , a common mediator of the acute inflammatory response. This might be expected given the potential role of IL-6, and perhaps other cytokines, in muscle regeneration following injury (see Kurek et al., 1996) . However, this is still somewhat puzzling given that myoblasts also express the IL-6 gene (Miller et al., 1988) and that basal secretion of IL-6 into the culture medium is greatly enhanced in the presence of TNF (Bartoccioni, et al., 1994) or macrophage secretory products (Cantini et al., 1995) . According to this relationship, and in the absence of clear data, one could hypothesize that TNF would induce proliferation via its amplification of IL-6 secretion. Thus, evaluation of the effect of immune challenge on growth and development of the offspring will require whole-animal studies in which the effects of potential secondary mediators are not precluded. Additionally, obtaining growth performance and composition of gain data from the offspring of challenged dams will provide insight as to whether growth potential is permanently altered.
Implications
The failure of commercially reared food animals to achieve their genetic potential for growth rate and efficiency of gain is undoubtedly attributable in part to serial pathogenic and nonpathogenic immunological challenges. Metabolically, the integrated response is one in which nutrients are repartitioned to immunerelated processes that take precedence over growth. The challenge for food animal scientists is to develop technologies that encompass all aspects of the challenge from management strategies to nutritional and therapeutic intervention. A thorough understanding of how and why cytokines and other immune modulators function in vivo during periods of immune challenge will be the foundation for improving animal well-being and producer profitability.
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